Taken together with the results of the subgroup analyses, STS did not have a significant effect on lowering the levels of IL-6 for patients with coronary artery disease and ischemic stroke, but it had a significant effect on patients who suffer from unstable angina and acute myocardial infarction. The gene discussed is IL6; the disease is ischemic stroke.